Dr. Jan Trøst Jørgensen holds a master’s degree in pharmaceutical science and a Ph.D. in clinical pharmacy from the University of Copenhagen. He has more than 35 years of experience with research and development in pharmaceutical, biotech and diagnostic companies as well as academia. Within the last 20 years, his focus has been on companion diagnostics and drug-diagnostic co-development within oncology. Currently he is the director of the Dx-Rx Institute, Fredensborg, Denmark
Research Keywords & Expertise
Oncology
Precision Medicine
targeted therapy
companion diagnostics
Predictive biomarkers
Drug-diagnostic codeve...
Fingerprints
35%
companion diagnostics
22%
Oncology
19%
Drug-diagnostic codevelopment
18%
Predictive biomarkers
11%
Precision Medicine
11%
targeted therapy
Short Biography
Dr. Jan Trøst Jørgensen holds a master’s degree in pharmaceutical science and a Ph.D. in clinical pharmacy from the University of Copenhagen. He has more than 35 years of experience with research and development in pharmaceutical, biotech and diagnostic companies as well as academia. Within the last 20 years, his focus has been on companion diagnostics and drug-diagnostic co-development within oncology. Currently he is the director of the Dx-Rx Institute, Fredensborg, Denmark